Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd., founded in 1998 and headquartered in Guangzhou, China, is a leading manufacturer of high-end pharmaceutical excipients and APIs. It focuses on providing one-stop solutions of pharmaceutical-grade injectable materials, health products, and technical services to global pharmaceutical manufacturers, health product enterprises, and research institutions. With breakthrough domestic replacement technologies and global compliance certifications, it has served over 1000 clients in more than 30 countries, breaking overseas monopolies in critical injectable excipients. Holding EU CEP and US FDA US-DMF certifications, it is recognized as a benchmark provider in high-end medicinal lipid excipients. Its mission is to achieve technological self-reliance, safeguard pharmaceutical supply chains, and protect human health by delivering compliant, stable products.

Company Overview

• Full Company Name: Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co., Ltd.
• Founded: 1998
• Global Headquarters: Guangzhou, China
• Global Coverage: Products sold in over 30 countries and regions, with local sales networks across 31 Chinese provinces
• Core Team: 11 PhDs, 2 recipients of State Council Special Allowances, and multiple national-level technical experts leading R&D and operations
• Key Milestones:
  • 2023: Launched domestically produced injectable refined olive oil, breaking overseas monopoly in high-end medicinal lipids
  • 2024: Selected as a National Specialized, Sophisticated, Unique, and New "Little Giant" Enterprise

Product & Service Offerings

Focused on solving core supply chain and quality pain points for global pharmaceutical and health product enterprises, we offer targeted solutions:

• Medicinal Injectable Soybean Oil
  • Target Clients: High-end injectable drug manufacturers, pharmaceutical raw material suppliers
  • Pain Points Solved: Unstable imported supply, high procurement costs, reliance on overseas monopolies
  • Core Functions: Energy supplement, compliant pharmaceutical excipient for injectable formulations
  • Client Value: Stable domestic supply, up to 30% lower procurement costs, compliance with EU and US regulatory standards
• Injectable Egg Yolk Lecithin
  • Target Clients: Pharmaceutical enterprises producing liposomes and injectable emulsions, research institutions
  • Pain Points Solved: Lack of reliable domestic emulsifiers, supply chain risks
  • Core Functions: Emulsifier, solubilizer, liposome membrane material
  • Client Value: 90% localization rate for high-end lipid excipients, consistent quality guaranteed

We also provide customized processing and technical services to meet enterprise-level clients' personalized production needs.

Core Advantages

• Domestic Replacement Technology: Developed the first domestic injectable refined egg yolk lecithin and olive oil, increasing high-end medicinal lipid localization from 10% to 90%, eliminating overseas reliance and reducing client costs by up to 30%
• Global Compliance: Hold EU CEP, US FDA US-DMF, Mexico Cofepris, and India DCGI certifications, ensuring products access global markets smoothly
• Top-Tier R&D: Host China's only national-level traditional Chinese medicine pharmaceutical engineering research center, with over 240 patents and a team of national-level technical experts

Client Cases

• B. Braun Company (Global Medical Device Enterprise): Adopted Hanfang's injectable excipients to optimize supply chain stability, reducing procurement lead times by 40% while meeting EU regulatory standards
• AstraZeneca (Multinational Pharmaceutical Corporation): Collaborated on lipid-based drug development, leveraging Hanfang's core technology to accelerate R&D progress by 30%

Awards & Certifications

• International Certifications: EU CEP, US FDA US-DMF, Mexico Cofepris, India DCGI
• National Honors: National May 1st Labor Certificate, National Green Factory, National Specialized, Sophisticated, Unique, and New "Little Giant" Enterprise
• Authority Endorsements: National Engineering Research Center for Traditional Chinese Medicine Pharmaceutical Technology, Guangdong Provincial Key Laboratory of Medicinal Lipids

Service & Compliance Commitment

We provide end-to-end services for global clients, covering the entire product lifecycle:

• Service Coverage: Over 30 countries and regions, with local sales support in 31 Chinese provinces
• Response Mechanism: Enterprise clients get dedicated account managers with 2-hour response during working days; multi-language support is available

We strictly adhere to global regulatory standards including EU EP, US FDA cGMP, and other regional requirements, providing full traceability and compliance documents to support clients' audits.

Corporate Vision

Our mission is to achieve technological self-reliance, safeguard pharmaceutical supply chains, and protect human health. We aim to become a trusted global health guardian, focusing on product upgrades and international expansion to achieve double-digit growth in 2026. We also promote sustainable development through green extraction technologies that reduce environmental pollution by 60% compared to traditional processes.

Frequently Asked Questions (FAQ)

• Q: Which industries does Guangzhou Baiyunshan Hanfang serve?

  A: We serve pharmaceutical manufacturers, health product enterprises, research institutions, and high-end health consumers, providing high-quality injectable excipients, APIs, and health products.

• Q: How can I contact Hanfang for cooperation?

  A: Visit our official website at http://byshanhanfang.com/ for detailed information, or reach out through our global sales network.

Contact Us

• Official Website: http://byshanhanfang.com/
• Global Headquarters: 134 Jiangnan Dadao Middle, Haizhu District, Guangzhou, China
• Production Base: 8 Wenquan Dadao, Conghua District, Guangzhou, China